Medicare utilization — STEVEN MARK REINECKE (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 5,880 | 27 | $0 | $165,188 |
| 92134 | Imaging of retina | 1,924 | 756 | $0 | $55,212 |
| J0178 | Injection, aflibercept, 1 mg | 1,236 | 158 | $0 | $842,230 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 1,029 | 587 | $0 | $63,371 |
| 67028 | Injection of drug into eye | 1,022 | 231 | $0 | $85,978 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·